524590 Stock Overview
Hemo Organic Limited engages in the manufacture and sale of ayurvedic or Unani pharmaceutical preparations in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Hemo Organic Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹10.50 |
| 52 Week High | ₹12.60 |
| 52 Week Low | ₹5.57 |
| Beta | 0.080 |
| 1 Month Change | -8.77% |
| 3 Month Change | 41.32% |
| 1 Year Change | 7.58% |
| 3 Year Change | -12.50% |
| 5 Year Change | -38.24% |
| Change since IPO | 486.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524590 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -14.8% | -0.8% | -2.0% |
| 1Y | 7.6% | 55.7% | 41.1% |
Return vs Industry: 524590 underperformed the Indian Pharmaceuticals industry which returned 55.7% over the past year.
Return vs Market: 524590 underperformed the Indian Market which returned 41.1% over the past year.
Price Volatility
| 524590 volatility | |
|---|---|
| 524590 Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524590's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 524590's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 2 | Dineshbhai Patel | www.hemoorganic.com |
Hemo Organic Limited engages in the manufacture and sale of ayurvedic or Unani pharmaceutical preparations in India. The company was formerly known as Dinesh Allorga Limited and changed its name to Hemo Organic Limited in August 2013. The company was incorporated in 1992 and is based in Anand, India.
Hemo Organic Limited Fundamentals Summary
| 524590 fundamental statistics | |
|---|---|
| Market cap | ₹35.01m |
| Earnings (TTM) | -₹855.74k |
| Revenue (TTM) | ₹1.70k |
Over9,999x
P/S Ratio-42.5x
P/E RatioIs 524590 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524590 income statement (TTM) | |
|---|---|
| Revenue | ₹1.70k |
| Cost of Revenue | ₹270.00 |
| Gross Profit | ₹1.43k |
| Other Expenses | ₹857.17k |
| Earnings | -₹855.74k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 84.12% |
| Net Profit Margin | -50,337.65% |
| Debt/Equity Ratio | -42.6% |
How did 524590 perform over the long term?
See historical performance and comparison